Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000412

Drug Information
NameDroperidol    
SynonymsCHEBI:4717; Dridol; luorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone; 1-1-[3-(p-Fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl-2-benzimidazolinone; 2-Benzimidazolinone, 1-[1-[3-(p-fluorobenz; McN-JR 4749; Spectrum4_000407; CCRIS 9070; NCGC00094884-02; 2H-Benzimidazol-2-one, 1-[1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl]-1,3-dihydro-; SPBio_002380; component of Innovar; Sintodril; Droperidolum [INN-Latin]; Innovan; Droleptan (TN); Thalamonal; NCGC00094884-01; Ina.psi.ne; LS-33253; 5-24-02-00388 (Beilstein Handbook Reference); Inapsin; IDI1_000103; Spectrum_001220; Droperidolo [DCIT]; Spectrum3_001426; 3-[1-[4-(4-fluorophenyl)-4-oxobutyl]-3,6-dihydro-2H-pyridin-4-yl]-1H-benzimidazol-2-one; HMS1569G21; Spectrum2_001386; Inappin; BRN 0579168; droperidol; Prestwick3_000360; Halkan; SPBio_001372; NCGC00016504-01; HS-0065; Droperidol [USAN:INN:BAN:JAN]; Inapsine; INAPSINE (TN); EINECS 208-957-8; HMS500F05; 1-[1-[3-(p-Fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone; 1-[1-[4-(p-Fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone; HMS2051L06; KBio2_004268; 2H-Benzimidazol-2-one, 1-(1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridinyl)-1,3-dihydro-; WLN: T56 BMVNJ D3- DT6N CUTJ A3VR DF; Ina.psi.n; Droleptan; Inoval; NSC 169874; SPECTRUM1501002; NSC169874; NCGC00016504-02; CHEBI:252751; Innovar-vet; L001006; MLS000028671; Inopsin; D1414_SIGMA; Prestwick_705; KBio1_000103; Sintosian; 548-73-2; Dehydrobenzperidol; R4749; CHEMBL1108; ZINC19796080; MLS001148120; DHBP; MLS002153445; BPBio1_000505; HMS1921B03; KBio2_006836; 1-1-[3-(p-Fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl-2-benzimidazolinone; UNII-O9U0F09D5X; Vetkalm; 1-(1-(4-(p-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone; Prestwick2_000360; Ino.psi.n; Properidol; Taylor Brand of Droperidol; KBioSS_001700; 1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydropyridin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one; SAM001247013; 1-(1-(3-(p-Fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone; BSPBio_000459; DivK1c_000103; Deidrobenzperidolo; Leptofen; Droperidol (JP15/USP/INN); 1-(1-(4-(4-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridinyl)-1,3-dihydro-2H-benzimidazol-2-one; 1-[1-[3-(p-Fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone; 1-[1-[4-(p-F; Prestwick0_000360; 2-Benzimidazolinone, 1-(1-(3-(p-fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-; Droperidolo; 2-Benzimidazolinone, 1-[1-[3-(p-fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl]-; BSPBio_003132; R 4749; R-4749; D004329; Spectrum5_001305; Janssen Brand of Droperidol; Droperidolum; DB00450; NINDS_000103; I14-2728; Thalamanol; MLS000758203; KBioGR_000674; KBio3_002352; CPD000058855; SMR000058855; D00308; McN-JR-4749; HMS2092O16; AC-3537; KBio2_001700; Prestwick1_000360; CAS-548-73-2; Dehydrobenzoperidol; Dehidrobenzperidol; C22H22FN3O2; oyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl]-; 2H-Benzimidazol-2-one, 1-[1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl]-1,3-dihydro-; AC1L1FBQ; Leptanal; HSDB 3320; Dihidrobenzperidol; Kern Brand of Droperidol; CID3168; BRD-K97158071-001-05-8    
Trade NameDropletan; Dridol; Inapsine    
CompanyJanssen Pharmaceutica    
IndicationNausea and vomitingApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAntipsychotic Agents    
CAS NumberCAS 548-73-2
FormularC22H22FN3O2    
PubChem Compound IDCID 3168.    
PubChem Substance IDSID 154359.    
SuperDrug ATC IDN01AX01;    
SuperDrug CAS ID000548732;    
TargetAlpha adrenergic receptorBinder[2]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 072123 To Reference
Ref 2Alpha-adrenergic blockade: a possible mechanism of tocolytic action of certain benzodiazepines in a postpartum rat model in vivo. Life Sci. 2003 Jan 24;72(10):1093-102. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543